Ireland
--:--IST
Latest
Clinical Trials in France / NCT06962215
Recruiting Not applicable

The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)

NCT06962215 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2025-05-15
Last updated
2026-06-23

Condition(s) studied

Brain Tumor Adult

Investigational drug(s) / intervention(s)

Paramedic training

Paramedic training: Nurses and care assistants at the centers randomized to the "with training" arm will undergo a day-and-a-half of training to help them support patients diagnosed with brain tumors. Training consists of half a day of theory, followed by a day of simulation.

Study summary

The goal of this clinical trial is to demonstrate that simulation training for paramedical staff in neurosurgery departments, in announcing and accompanying patients with a brain tumor, improves patient satisfaction when a (potentially malignant) brain tumor is discovered, compared with usual care.

The main question it aims to answer is:

\- Are patients more satisfied (as measured by scores on the EORCT IN-PATSAT32 questionnaire) with their neurosurgical hospitalization following the discovery of a brain tumor in centers where paramedics have been trained by simulation?

Researchers will compare the results of the EORTC IN-PATSAT32 questionnaire to determine whether paramedic training improves patient satisfaction between simulation-trained and untrained centers.

Participants will be asked to complete the EORT IN-PATSAT32 questionnaire at the end of their hospital stay.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient over 18 years of age * Patient covered by a social security scheme * Patient signed informed consent form * Patient found to have a brain tumor (potentially malignant, primary or secondary if this is the mode of entry into the disease) * Hospitalization in the Neurosurgery Department at the time of tumor discovery, before the histological diagnosis is announced. Exclusion Criteria: * Patients with a personal history of cancer * Patient without family AND unable to receive information

Primary outcome measure(s)

Trial sites (11)

FacilityCityRegionStatus
CHU Brest Brest Brittany Region Not Yet Recruiting
CHU Amiens Amiens France Not Yet Recruiting
CHU Angers Angers France Not Yet Recruiting
CHU Bordeaux Bordeaux France Not Yet Recruiting
APHM Nord Marseille France Not Yet Recruiting
CHU Nantes Nantes France Not Yet Recruiting
CHU Nice Nice France Not Yet Recruiting
CHU Rouen Rouen France Not Yet Recruiting
CHU Saint Etienne Saint-Etienne France Recruiting
CHU Strasbourg Strasbourg France Not Yet Recruiting
CHU Tours Tours France Not Yet Recruiting

More University Hospital, Brest trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06962215 on ClinicalTrials.gov ↗ ← All trials in France